Key result
Obstructive sleep apnea, lifestyle factors, and chronic kidney disease are the most prevalent etiologies of treatment-resistant hypertension among African American adults, requiring individualized management.
Why the study?
African American adults with treatment-resistant hypertension face a huge management gap resulting in increased cardiovascular disease risk, with a paucity of literature addressing underlying etiologies and management in this population.
Thorough diagnostic testing for underlying conditions like OSA, CKD, and lifestyle factors is essential for the successful management of treatment-resistant hypertension in African American adults.
Answers are grounded in this paper and cite their sources.
May warrant etiology-specific evaluation in African American adults with resistant hypertension; leaves open optimal strategies pending prospective trials.
Treatment-resistant hypertension (TRH) is defined as blood pressure levels that remain above the therapeutic goal despite concurrent use of three or more antihypertensive medications taken at maximally tolerated doses, one of which should be a diuretic. Additionally, individuals on four or more antihypertensive agents regardless of blood pressure are also considered to have TRH. Amongst people diagnosed with TRH, African American adults face a huge management gap, resulting in increased cardiovascular disease risk. The primary objective of this review was to identify the commonly encountered etiologies and extensively discuss the current management strategies of TRH with a particular focus on African Americans. Relevant studies were identified by analyzing scientific databases and journals such as PubMed, Cochrane, MEDLINE, Cureus, and American Heart Association (AHA). The studies identified and examined common causes of TRH, describing their pathophysiology and highlighting different treatment options for the respective etiologies. The most prevalent etiologies of TRH amongst African Americans were chronic kidney disease (CKD), renal artery stenosis (RAS), fibromuscular dysplasia, obstructive sleep apnea (OSA), endocrine causes (Conn syndrome, Cushing syndrome, etc.), sympathetic nervous system overactivity, lifestyle factors, inaccurate blood pressure measurement, and inappropriate treatment. Of the etiologies reviewed, OSA, lifestyle factors, and CKD exhibited a striking prevalence among the subpopulation studied. Unfortunately, there was a paucity of articles addressing this topic amongst African Americans, and therefore there was not a substantial appreciation of the prevalence of some of the identified etiologies in the population of interest. Thorough diagnostic testing for associated or underlying conditions provides a basis for successful management. This review brought to the fore the need for doctors and patients to collaborate in order to improve TRH management and help patients lead healthier lives.
No takes yet. Share an insight, caveat, or question.
Odion-Omonhimin et al. (2022) conducted a review in Treatment-Resistant Hypertension. Etiology identification and management strategies was evaluated. Obstructive sleep apnea, lifestyle factors, and chronic kidney disease are the most prevalent etiologies of treatment-resistant hypertension among African American adults, requiring individualized management.
Synapse has enriched 10 related papers. Consider them for comparative context: